Tag Archives: DEA

DEA finalizing Schedule II status for synthetic THC drug Syndros

Published: Nov 21, 2017, 8:50 am • Updated: Nov 21, 2017, 9:36 am By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration this week will grant Schedule II status to a synthetic THC drug developed by a pharmaceutical

DEA finalizes quota of government-grown marijuana for 2018 research: 978 pounds

Published: Nov 7, 2017, 4:59 pm • Updated: Nov 7, 2017, 4:59 pm By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration this week will formalize its production quotas of drugs and substances utilized for medical, scientific and

Jeff Sessions calls for “more competition” among medical marijuana growers for research

Published: Oct 18, 2017, 9:45 am • Updated: Oct 18, 2017, 10:12 am By Polly Washburn, The Cannabist Staff In testimony before the Senate Judiciary Committee on Wednesday morning, U.S. Attorney General Jeff Sessions said there should be “more competition”

How Congress helped drug company lobbyists derail the DEA’s war on opioids

Published: Oct 16, 2017, 9:13 am • Updated: Oct 16, 2017, 9:41 am By Lenny Bernstein and Scott Higham, The Washington Post In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the

CBD on the international stage: WHO committee delving into science, control status of cannabis compound

Published: Sep 20, 2017, 1:58 pm • Updated: Sep 20, 2017, 5:42 pm By Alicia Wallace, The Cannabist Staff Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise — but marijuana- and hemp-derived extracts rich in CBD and